CFDE Data Portal | Search LINC02078

	Label	Description
	LINC02078 Gene (Entity type)	ENSG00000267719 - long intergenic non-protein coding RNA 2078
	GSE189035 inositol 2 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE119978 GSE180930 cisplatin 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE140758 MDM2 inhibition 4 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE119424 GSE120214 TBXT brachyury inhibition 5 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE237216 STAT1 knockout RPMI-8226 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE150244 TRIM8 knockout 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE237361 PARP BRCA1 inhibition 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Ovary 20-29 vs 40-49 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Bladder 20-29 vs 40-49 Up Gene Set (Entity type)	A Gene Set from GTEx

LINC02078

ENSG00000267719 - long intergenic non-protein coding RNA 2078

GSE189035 inositol 2 v 4 human dn

A Gene Set from LINCS

GSE119978 GSE180930 cisplatin 3 v 1 human dn

A Gene Set from LINCS

GSE140758 MDM2 inhibition 4 v 1 human dn

A Gene Set from LINCS

GSE119424 GSE120214 TBXT brachyury inhibition 5 v 4 human up

A Gene Set from LINCS

GSE237216 STAT1 knockout RPMI-8226 1 v 3 human up

A Gene Set from LINCS

GSE150244 TRIM8 knockout 2 v 0 human dn

A Gene Set from LINCS

GSE237361 PARP BRCA1 inhibition 2 v 0 human dn

A Gene Set from LINCS

GTEx Ovary 20-29 vs 40-49 Up

A Gene Set from GTEx

GTEx Bladder 20-29 vs 40-49 Up

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.